Targeting the TGF-β receptor with kinase inhibitors for scleroderma therapy.
Cong, Lin
Targeting the TGF-β receptor with kinase inhibitors for scleroderma therapy. [electronic resource] - Archiv der Pharmazie Sep 2014 - 609-15 p. digital
Publication Type: Journal Article
1521-4184
10.1002/ardp.201400116 doi
Heterocyclic Compounds, 3-Ring--chemistry
Humans
Imidazoles--chemistry
Molecular Docking Simulation
Molecular Dynamics Simulation
Molecular Structure
Molecular Targeted Therapy
Morpholines--chemistry
Protein Binding
Protein Kinase Inhibitors--chemistry
Pyrazoles--chemistry
Quinolines--chemistry
Quinoxalines--chemistry
Receptors, Transforming Growth Factor beta--antagonists & inhibitors
Scleroderma, Systemic--drug therapy
Targeting the TGF-β receptor with kinase inhibitors for scleroderma therapy. [electronic resource] - Archiv der Pharmazie Sep 2014 - 609-15 p. digital
Publication Type: Journal Article
1521-4184
10.1002/ardp.201400116 doi
Heterocyclic Compounds, 3-Ring--chemistry
Humans
Imidazoles--chemistry
Molecular Docking Simulation
Molecular Dynamics Simulation
Molecular Structure
Molecular Targeted Therapy
Morpholines--chemistry
Protein Binding
Protein Kinase Inhibitors--chemistry
Pyrazoles--chemistry
Quinolines--chemistry
Quinoxalines--chemistry
Receptors, Transforming Growth Factor beta--antagonists & inhibitors
Scleroderma, Systemic--drug therapy